Takeda Partners with Indonesia to Expand Plasma Medicine Access
OSAKA, Japan; CAMBRIDGE, Massachusetts; JAKARTA, Indonesia — July 13, 2026 Takeda has entered into a landmark collaboration with the...
Alamar Biosciences
Advertisement
Alamar Launches National Blood Biomarker Initiative for ADRD
FREMONT, California, July 13, 2026 Alamar Biosciences has partnered with leading U.S. research universities to launch a national-scale proteomics...
ALZpath Expands Global Leadership in Alzheimer’s Blood Biomarkers
CARLSBAD, California, July 13, 2026 ALZpath, Inc. has announced a major scientific milestone at the Alzheimer’s Association International Conference...
Philips Gains FDA Clearance for AI Ultrasound Upgrade
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
Alamar Launches NULISA Kit for Home-Based Proteomics
FREMONT, California, USA, June 2, 2026 Alamar Biosciences has unveiled its NULISA™ Dried Blood Spot (DBS) Extraction Kit, a...
Advertisements
Alamar Launches Neuro 220 Panel for Precision Proteomics
Fremont, California, March 17, 2026 Alamar Biosciences, Inc. announced the launch of its NULISAseq™ Neuro 220 Panel, a next-generation...
Alamar Biosciences Launches Blood-Based pTau217 Assay for Alzheimer’s Research
FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ — Alamar Biosciences, a leader in precision proteomics, today announced the launch of...
Advertisement
